Alto Neuroscience, Inc. ( ANRO) - Key Metrics
ANRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.65 | -$0.46 | -$0.46 |
| 2026Q1 | $0 | -$0.80 | -$0.82 | -$0.84 |
| 2025Q4 | $0 | -$0.51 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.52 | -$0.37 | -$0.37 |
| 2025Q2 | $0 | -$0.65 | -$0.51 | -$0.51 |
ANRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.15 |
| 2026Q1 | 0% | -7.02 |
| 2025Q4 | 0% | -8.73 |
| 2025Q3 | 0% | -1.93 |
| 2025Q2 | 0% | -0.85 |
ANRO
Price: $21.94
52 week price:
Earnings Per Share: -2.32 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 825.4 million